Navigation Links
Galileo Analytics Announces Agreement to Provide Analytic Component of ASCO's CancerLinQ Prototype
Date:12/13/2012

WASHINGTON, Dec. 13, 2012 /PRNewswire/ -- Galileo Analytics announced today that the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer, has selected the Galileo Cosmos™ platform to serve as an analytic component of the CancerLinQ™ prototype, the first phase of the society's multi-phase effort to build a "rapid-learning system" in cancer care.

Galileo will provide real-time visual data mining and advanced analytics within the de-identified data of the breast cancer-specific prototype.  The ability to visually explore complex data and perform sophisticated analytics in real-time is at the essence of CancerLinQ.

ASCO's vision for CancerLinQ is a comprehensive, knowledge-generating computer network, which will pull in data from a variety of sources and make that data accessible and understandable to health care providers, researchers and patients.  Through CancerLinQ, ASCO seeks to speed the generation of new knowledge and understanding, so the cancer community can learn from all patients, not just the small percentage who participate in clinical trials.

The development of the prototype will allow ASCO to determine and overcome technological barriers to creating a more robust system encompassing all types of cancer, as well as identify requirements around the use of data standards.

"We are honored to be a part of the development of the CancerLinQ prototype," said Simon Fitall, CEO, Galileo Analytics.  "We designed Galileo Cosmos to enable the rapid exploration of the most complex health data available.  Our vision is to move data research out of the computer lab and into the hands of physicians, researchers and caregivers, giving them the power to find the meaningful connections that will improve care.  CancerLinQ embodies that vision, and we're thrilled to be part of making it a reality." 

For more information about CancerLinQ, visit www.asco.org/CancerLinQ.

About Galileo Analytics
Galileo Analytics is an advanced health data analytics and visual data mining company, which aims to democratize health data research. Galileo's visual data mining platform, Galileo Cosmos™, provides data researchers of all levels with an easy-to-use, cloud-based interface that enables real-time analysis of complex health data. For more information about Galileo Analytics and Galileo Cosmos™, visit www.galileoanalytics.com.

NOTE: ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission.  ASCO® is not a partner or affiliate of Galileo Analytics and does not recommend or endorse any vendor, product, or service.


'/>"/>
SOURCE Galileo Analytics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Accountable Care and Value-Based Purchasing Drives Adoption of Advanced Solutions for Health Data Analytics, Finds Frost & Sullivan
2. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
3. Medstreaming Launches Web-Based Analytics for All in One EMR/PACS/Practice Management Platform at HIMSS
4. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida
5. Accelr8 Announces NASDAQ Capital Market Listing
6. XBiotech Announces Positive Phase II Clinical Trial Results for Lead Candidate MABp1 in Acne Vulgaris
7. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
8. Career Confidential Announces Release of New E-book About Using Recruiters
9. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
10. Innosight Announces Leadership Transition
11. My Cleaning Products Announces its Christmas Special, Sells Rusterizer at 20% Less
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... COPENHAGEN, Denmark , Feb. 3, 2016 ... stage biotechnology company that applies its innovative TransCon technology ... to present at an upcoming investor conference.Event:2016 Leerink Partners ... York, NY Date:  , Wednesday, February 10, 2016 Time:  ... --> www.ascendispharma.com . --> An audio ...
(Date:2/3/2016)... 3, 2016 New Jersey Health Foundation (NJHF) ... million for researchers in New Jersey ... that demonstrates exciting potential.   James ... the New Jersey Health Foundation Research Grant Program ... educational institutions— Princeton University, Rutgers University, Rowan University ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... series of potential targets (epitopes) specific to misfolded, propagating strains of Amyloid beta ... specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the first misfolded ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... events annual report which summarizes and analyzes nearly 750 unique supply ... monitoring, alert, and analysis service. , Supply chain risk management practitioners subscribe ...
Breaking Biology Technology:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):